Methods for treating disseminated intravascular coagulation by inhibiting MASP-2 dependent complement activation

Details for Australian Patent Application No. 2010306581 (hide)

Owner Omeros Corporation University of Leicester

Inventors Schwaeble, Hans-wilhelm; Dudler, Thomas A.; Tedford, Clark E.; Parent, James B.; Demopulos, Gregory A.

Agent Freehills

Pub. Number AU-A-2010306581

PCT Pub. Number WO2011/047346

Priority 61/279,279 16.10.09 US; 61/322,722 09.04.10 US

Filing date 15 October 2010

Wipo publication date 21 April 2011

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

10 May 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 17 Apr 2012

10 May 2012 PCT application entered the National Phase

  PCT publication WO2011/047346 Priority application(s): WO2011/047346

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010306593-Biomarkers and methods for measuring and monitoring inflammatory disease activity

2010306576-Treatment of suicidal ideation or behavior using inhibitors of nicotinic acetylcholine receptors